U.S. markets closed

MediPharm Labs Corp. (MEDIF)

Other OTC - Other OTC Delayed Price. Currency in USD
Add to watchlist
0.3386-0.0042 (-1.23%)
At close: 3:59PM EDT

MediPharm Labs Corp.

151 John Street
Barrie, ON L4N 2L1
705 719 7425

IndustryDrug Manufacturers—Specialty & Generic
Full Time Employees204

Key Executives

NameTitlePayExercisedYear Born
Mr. Keith StrachanCo-Founder, Pres, Interim CEO & Director234.59kN/AN/A
Mr. Greg HunterChief Financial OfficerN/AN/AN/A
Mr. Warren EverittCEO of Asia Pacific & Director181.67kN/AN/A
Mr. Saravan SubramaniamVP of Operations & Supply ChainN/AN/AN/A
Mr. Ahmed ShehataGen. Counsel & Head of Corp. Devel.N/AN/AN/A
Mr. Brett MoonVP of SalesN/AN/AN/A
Mr. Kirk BinnsExec. VP of Global AccountsN/AN/AN/A
Mr. Nigel DewsburyHead of QualityN/AN/AN/A
Amounts are as of December 31, 2020 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.


MediPharm Labs Corp., together with its subsidiaries, produces and sells pharmaceutical-grade cannabis oil and concentrates, and advance derivative products in Canada and Australia. It formulates, processes, packages, and distributes cannabis extracts and cannabinoid-based products. The company was founded in 2015 and is headquartered in Barrie, Canada.

Corporate Governance

MediPharm Labs Corp.’s ISS Governance QualityScore as of July 1, 2021 is 9. The pillar scores are Audit: 9; Board: 10; Shareholder Rights: 4; Compensation: 7.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.